Abstract
Green synthesis of novel compounds 4-(2-carboxybenzamido)-2-hydroxybenzoic acids 3a-3e, 4-(1, 3- dioxoisoindolin-2-yl)-2-hydroxybenzoic acids 4a-4e, 2-acetoxy-4-(2-carboxybenzoylamino)benzoic acids 6a-6e and 2- acetoxy-4-(1, 3-dioxo-1, 3-dihydroisoindol-2-yl)-benzoic acids 8a-8e has been developed which were analogs of aspirin (used as analgesic, anti-pyretic and cardiovascular drug) and para-aminosalicylic acid ( used as anti-tuberculosis agent).
Keywords: Phthalic anhydrides, p-aminosalicylic acid, analgesic, antipyretic & anti-tuberculosis agents.
Letters in Organic Chemistry
Title:Green Synthesis of Novel Phthalimide Derivatives of Aspirin and P-aminosalicylic Acid as Potential Analgesic- antipyretic and Anti-tuberculosis Agents
Volume: 11 Issue: 4
Author(s): Yervala D. Reddy, Chittireddy V.R. Reddy and Pramod K. Dubey
Affiliation:
Keywords: Phthalic anhydrides, p-aminosalicylic acid, analgesic, antipyretic & anti-tuberculosis agents.
Abstract: Green synthesis of novel compounds 4-(2-carboxybenzamido)-2-hydroxybenzoic acids 3a-3e, 4-(1, 3- dioxoisoindolin-2-yl)-2-hydroxybenzoic acids 4a-4e, 2-acetoxy-4-(2-carboxybenzoylamino)benzoic acids 6a-6e and 2- acetoxy-4-(1, 3-dioxo-1, 3-dihydroisoindol-2-yl)-benzoic acids 8a-8e has been developed which were analogs of aspirin (used as analgesic, anti-pyretic and cardiovascular drug) and para-aminosalicylic acid ( used as anti-tuberculosis agent).
Export Options
About this article
Cite this article as:
Reddy D. Yervala, Reddy V.R. Chittireddy and Dubey K. Pramod, Green Synthesis of Novel Phthalimide Derivatives of Aspirin and P-aminosalicylic Acid as Potential Analgesic- antipyretic and Anti-tuberculosis Agents, Letters in Organic Chemistry 2014; 11 (4) . https://dx.doi.org/10.2174/1570178610666131210234152
DOI https://dx.doi.org/10.2174/1570178610666131210234152 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Computer-Aided Drug Design Developments of Corey-Chaykovsky in Organic Reactions and Total Synthesis of Natural Products
Current Organic Synthesis Analysis of DNA Microarray Data
Current Topics in Medicinal Chemistry Editorial [ The Medicinal Chemistry of Anti-Infectious Agents Guest Editor: Concepcion Gonzalez-Bello ]
Current Topics in Medicinal Chemistry Spices Chemoconstituents as Persuasive Inhibitor of S. typhimurium Virulent Protein L-asparaginase
Letters in Drug Design & Discovery Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery
Current Topics in Medicinal Chemistry Antitubercular Drug Development: Current Status and Research Strategies
Mini-Reviews in Medicinal Chemistry The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Crohns Targeted Therapy: Myth or Real Goal?
Current Drug Discovery Technologies Anti-Microbial
Current Bioactive Compounds Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Comparison of HCV Core and CoreE1E2 Virus-Like Particles Generated by Stably Transfected Leishmania tarentolae for the Stimulation of Th1 Immune Responses in Mice
Current Drug Delivery Pharmacogenetics and Inflammatory Bowel Disease
Current Pharmacogenomics and Personalized Medicine QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
Current Pharmaceutical Design Tubercidin and Related Analogues: An Inspiration for 50 years in Drug Discovery
Current Organic Chemistry Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets Recent Patents on Immunoregulatory DNA Vaccines for Autoimmune Diseases and Allograft Rejection
Recent Patents on DNA & Gene Sequences Synthesis, <i>In silico</i> and <i>In vitro</i> Analysis of Hydrazones as Potential Antituberculosis Agents
Current Computer-Aided Drug Design Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Current Signal Transduction Therapy